Tanzeum (Albiglutide): A Once-Weekly GLP-1 Receptor Agonist Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes (Q43148352)
Jump to navigation
Jump to search
scientific article published in March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tanzeum (Albiglutide): A Once-Weekly GLP-1 Receptor Agonist Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes |
scientific article published in March 2015 |
Statements
1 reference
Tanzeum (Albiglutide): A Once-Weekly GLP-1 Receptor Agonist Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes (English)
1 reference
Loretta Fala
1 reference
1 reference